Multiple myeloma

You are here: 

Consolidation therapy for multiple myeloma

Consolidation therapy for multiple myeloma is given after a stem cell transplant. It’s a short course of chemotherapy that helps make the previous chemotherapy treatment and stem cell transplant work better. Consolidation therapy also helps to keep the multiple myeloma in remission for longer.

Consolidation therapy for people with multiple myeloma who have had a stem cell transplant is most often the VRD regimen. The VRD regimen uses bortezomib (Velcade), lenalidomide (Revlimid) and dexamethasone (Decadron, Dexasone).

Stories

Researcher Dr Harvey Chochinov Dr Harvey Chochinov revealed that asking a simple question can improve cancer care.

Learn more

Access to services in your community

Illustration of houses side-by-side

The Canadian Cancer Society’s Community Services Locator helps cancer patients and their families find the services and programs they need in their community.

Learn more